Broadfin Capital, LLC
New York, NY · CIK 1511901 · 13F filing filed 2020-02-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityBROADFIN CAPITAL, LLC (US)
- Others nearbyNew York, NY
$402.6m
reported value
35positions
50.0%in top 10
—no comparable previous quarter
Options: 2 call positions ($36.7m notional), 3 put positions ($307.4m notional) – listed below, not included above.
This report includes the holdings of 1 other manager that shares the investment decisions:
- Broadfin Healthcare Master Fund Ltd – no 13F of its own this quarter
Shares in two reports are counted once in each security's totals.
Holdings, Q4 2019
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIODELIVERY SCIENCES INTL IN BDSI | $27.2m6.75% | — |
| VIEWRAY INC VRAYQ | $23.5m5.84% | — |
| AMARIN CORP PLC SPONS ADR NEW | $22.5m5.59% | — |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $22.3m5.53% | — |
| ALKERMES PLC ALKS | $21.1m5.24% | — |
| QUOTIENT LTD SHS | $19.0m4.71% | — |
| EIGER BIOPHARMACEUTICALS INC CLDN | $18.4m4.58% | — |
| STAAR SURGICAL CO STAA | $16.3m4.04% | — |
| INTERSECT ENT INC XENT | $15.7m3.90% | — |
| PROGENICS PHARMACEUTICALS IN PGNX | $15.6m3.87% | — |
| NANOSTRING TECHNOLOGIES INC NSTG | $15.5m3.84% | — |
| IOVANCE BIOTHERAPEUTICS INC IOVA | $14.8m3.67% | — |
| DERMIRA INC DERM | $13.6m3.37% | — |
| RECRO PHARMA INC REPH | $13.2m3.28% | — |
| LANTHEUS HLDGS INC LNTH | $12.7m3.15% | — |
| VAPOTHERM INC COM | $12.2m3.03% | — |
| SIENTRA INC SIEN | $11.5m2.86% | — |
| VERICEL CORP VCEL | $10.8m2.68% | — |
| LA JOLLA PHARMACEUTICAL CO LJPC | $10.6m2.62% | — |
| ALEXION PHARMACEUTICALS INC ALXN | $9.0m2.23% | — |
| SOL GEL TECHNOLOGIES SLGL | $8.9m2.22% | — |
| RELMADA THERAPEUTICS INC RLMD | $8.6m2.14% | — |
| AURINIA PHARMACEUTICALS INC AUPH | $8.1m2.01% | — |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $7.8m1.93% | — |
| EXICURE INC XCUR | $7.7m1.92% | — |
| ZOGENIX INC ZGNX | $7.0m1.75% | — |
| ICU MED INC ICUI | $5.6m1.39% | — |
| LUMINEX CORP DEL COM | $4.8m1.19% | — |
| STRATA SKIN SCIENCES INC SSKN | $3.8m0.95% | — |
| ANAPTYSBIO INC ANAB | $3.6m0.89% | — |
| ACLARIS THERAPEUTICS INC ACRS | $3.6m0.89% | — |
| MYLAN NV MYL | $3.0m0.75% | — |
| HERON THERAPEUTICS INC HRTX | $2.1m0.52% | — |
| SCYNEXIS INC COM | $1.8m0.45% | — |
| PALATIN TECHNOLOGIES INC COM PAR $ .01 | $819.0k0.20% | — |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $141.6m440.0k shares | — |
| ISHARES TR IWM · Put | $132.5m800.0k shares | — |
| SPDR SER TR XBI · Put | $33.3m350.0k shares | — |
| BIOHAVEN PHARMACTL HLDG CO L BHVN · Call | $32.7m600.0k shares | — |
| ALKERMES PLC ALKS · Call | $4.1m200.0k shares | — |